HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Portfolio Tracker
Get an update on your stocks every day. See earnings revisions, new reports and Zacks Rank changes at a glance. Click here to learn more.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


SNY: Sanofi Aventis - Full Company Report Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Full Company Report |  Estimates |  Brokerage Recommendations |  Comparison to Industry |  Insiders |  Brokerage Reports |  Zacks Equity Research   |  Annual Report
SANOFI AVENTIS (NYSE)
SNY 37.67 -0.01 (-0.03%) Vol.  1,097,541 16:02 ET
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.

 General Information
SANOFI-AVENTIS
174 avenue de France
Paris, - 75013
Phone: 335 377 4076
Fax: 335 377 4174
Web: www.sanofi-synthelabo.com
Email: None
 
Industry MED PRODUCTS
Sector: Medical
 
Fiscal Year End December
Last Reported Quarter 09/30/09
Next EPS Date 02/10/2010
 
 Price and Volume Information
Zacks Rank
Yesterday's Close 37.68
52 Week High 40.17
52 Week Low 24.59
Beta 0.83
20 Day Moving Average 1,513,110.75
Target Price Consensus 42.31
 
 % Price Change
4 Week -3.90
12 Week 9.09
YTD 17.13
 % Price Change Relative to S&P 500
4 Week -4.94
12 Week 2.85
YTD -3.06
 Share Information
Shares Outstanding (millions) 2,631.05
Market Capitalization (millions) 99,111.69
Short Ratio 2.32
Last Split Date N/A
 Dividend Information
Dividend Yield 2.97%
Annual Dividend $1.12
Payout Ratio 0.25
Change in Payout Ratio -0.01
Last Dividend Payout / Amount NA / $0.00

 EPS Information
Current Quarter EPS Consensus Estimate 1.09
Current Year EPS Consensus Estimate 4.74
Estimated Long-Term EPS Growth Rate 3.20
Next EPS Report Date 02/10/2010
 Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell) 2.00
30 Days Ago 2.06
60 Days Ago 2.28
90 Days Ago 2.44

 Fundamental Ratios
 P/E
Current FY Estimate: 7.95
Trailing 12 Months: 8.33
PEG Ratio 2.51
 EPS Growth
vs. Previous Year 17.76%
vs. Previous Quarter 1.61%
 Sales Growth
vs. Previous Year 7.84%
vs. Previous Quarter: 3.21%
 Price Ratios
Price/Book 1.63
Price/Cash Flow 5.16
Price / Sales 2.45
 ROE
09/30/09 18.29
06/30/09 17.50
03/31/09 16.22
 ROA
09/30/09 11.02
06/30/09 10.54
03/31/09 10.02
 Current Ratio
09/30/09 -
06/30/09 1.72
03/31/09 -
 Quick Ratio
09/30/09 -
06/30/09 1.32
03/31/09 -
 Operating Margin
09/30/09 28.60
06/30/09 27.91
03/31/09 26.77
 Net Margin
09/30/09 -
06/30/09 -
03/31/09 -
 Pre-Tax Margin
09/30/09 -
06/30/09 -
03/31/09 -
 Book Value
09/30/09 -
06/30/09 23.10
03/31/09 -
 Inventory Turnover
09/30/09 -
06/30/09 -
03/31/09 -
 Debt-to-Equity
09/30/09 -
06/30/09 0.16
03/31/09 -
 Debt to Capital
09/30/09 -
06/30/09 13.80
03/31/09 -

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research